Analyst Price Targets — AFIB
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 24, 2022 9:18 am | — | BTIG | $1.50 | $0.57 | Benzinga | BTIG Maintains Buy on Acutus Medical, Lowers Price Target to $1.5 |
Latest News for AFIB
Reviewing T2 Biosystems (NASDAQ:TTOO) & Acutus Medical (NASDAQ:AFIB)
Risk and Volatility Acutus Medical has a beta of -1.28, meaning that its stock price is 228% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Profitability This table compares Acutus Medical and T2 Biosystems' net margins,
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AFIB.
U.S. House Trading
No House trades found for AFIB.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.